RSV Diagnostics Market Demand, Trends, Size, Share and Revenue Forecast 2022-2027
IMARC Group has recently released a new research study titled "Respiratory Syncytial Virus (RSV) Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", The global respiratory syncytial virus (RSV) diagnostics market size reached US$ 832.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,439.2 Million by 2027, exhibiting a growth rate (CAGR) of 9.7% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
RSV Diagnostics Market Trends and Drivers:
The improving healthcare infrastructures and the increasing focus of parents on child medical care are driving the RSV diagnostics market. Since RSV infection is generally more serious in children under two years of age, favorable government policies for the treatment of hospitalized infants are catalyzing the RSV diagnostics market growth. Furthermore, the easy availability of diagnostic modalities and the high survival rates after early diagnosis are contributing to the global market. Moreover, the introduction of biotechnology-based procedures is facilitating the development of modern detection systems, such as enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (PCR), western blot, direct immunofluorescence, etc. This, in turn, is anticipated to augment the RSV diagnostics market over the forecasted period.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Request to get the sample report: https://www.imarcgroup.com/respiratory-syncytial-virus-diagnostics-market/requestsample
Market Outlook:
Respiratory syncytial virus (RSV) refers to a viral infection of the respiratory tract and lungs, which can cause pneumonia, middle ear infection, asthma, and even death. It can be diagnosed by chest x-rays, a swab of secretions, blood tests, and pulse oximetry by checking for signs such as lung inflammation, oxygen levels, and white blood cell (WBC) count in the blood. Some commonly available treatment options for RSV include intravenous (IV) fluids, mechanical ventilation, over-the-counter (OTC) medications, humidified oxygen, inhaled bronchodilators, etc.
Competitive Analysis and Segmentation:
Major Players Covered:
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Coris BioConcept
- DiaSorin Molecular LLC (DiaSorin Inc)
- Hoffmann-La Roche AG
- Merck KGaA
- Quest Diagnostics Incorporated
- Quidel Corporation
- Thermo Fisher Scientific Inc.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Direct Fluorescent Antibody (DFA) Method
- Rapid Antigen Diagnostic Test (RADTs)
- Molecular Diagnostics
- Chromatographic Immunoassay
- Diagnostic Imaging
- Gel Microdroplets
- Flow Cytometry
- Others
Breakup by End Use:
- Hospitals and Clinics
- Laboratory
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=4048&flag=C
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
%20Diagnostics%20Market.png)